Clinical trial
Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination…
NCT00197171 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00197171 |
|---|---|
| Title | Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine |
| Official title | Evaluate the Persistence of Immune Response of GSK Biologicals' TWINRIX™ ADULT, Administered According to 0,6 Month Schedule and 0,12 Month Schedule, in Volunteers Aged 12-15 Years Inclusive at the Time of First Vaccine Dose |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Hepatitis A |
| Intervention type | Biological |
| Interventions | Combined Hepatitis A and B vaccine |
| Enrollment | 143 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | Sep 20, 2005 |
| Last update posted | Sep 7, 2016 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: